Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Fossati

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Refractive Surgery (Thorofare, N.J. : 1995)|December 8, 2022
Camellens FIL622-1 IOL Implantation in the Ciliary Sulcus: Refractive Outcomes and Optimization of A-constantGiovanni Fossati, Jose Luis Vallejo-Garcia, Raffaele Raimondi, et al.
Journal of Clinical Medicine|March 11, 2023
Trans-Scleral Plugs Fixated FIL SSF IOL: A Review of the Literature and Comparison with Other Secondary IOL ImplantsRaffaele Raimondi, Tania Sorrentino, Raphael Kilian, et al.
Retinal Cases & Brief Reports|September 10, 2025
MODIFIED PRO RE NATA REGIMEN OF BROLUCIZUMAB IN TREATMENT-NAIVE NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONMyrta Lippera, Alessandro Feo, Claudia Del Turco, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Refractive Surgery (Thorofare, N.J. : 1995)|December 8, 2022
Camellens FIL622-1 IOL Implantation in the Ciliary Sulcus: Refractive Outcomes and Optimization of A-constantGiovanni Fossati, Jose Luis Vallejo-Garcia, Raffaele Raimondi, et al.
Journal of Clinical Medicine|March 11, 2023
Trans-Scleral Plugs Fixated FIL SSF IOL: A Review of the Literature and Comparison with Other Secondary IOL ImplantsRaffaele Raimondi, Tania Sorrentino, Raphael Kilian, et al.
Retinal Cases & Brief Reports|September 10, 2025
MODIFIED PRO RE NATA REGIMEN OF BROLUCIZUMAB IN TREATMENT-NAIVE NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONMyrta Lippera, Alessandro Feo, Claudia Del Turco, et al.
Pageof 2